Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 21 Carcinoma, Non-Small-Cell Lung 16 Pancreatic Neoplasms 11 Neoplasm Metastasis 11 Prostatic Neoplasms 9 Melanoma 9 Lung Neoplasms 8 Glioblastoma 8 Breast Neoplasms 8 Carcinoma, Hepatocellular 7 Squamous Cell Carcinoma of Head and Neck 6 Glioma 6 Carcinoma, Renal Cell 6 Neoplasms 5 Colorectal Neoplasms 5 Head and Neck Neoplasms 4 Uveal Melanoma 3 Oligodendroglioma 3 Liver Neoplasms 3 Gliosarcoma 3 Astrocytoma 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2

Interventions

Cyclophosphamide 14 Gemcitabine 6 Filgrastim 6 fludarabine 5 Methotrexate 5 Leucovorin 5 Granulocyte Colony-Stimulating Factor 5 Zoledronic Acid 4 Temozolomide 4 Mesna 4 Irinotecan 4 Ifosfamide 4 Etoposide 4 Cisplatin 4 Carboplatin 4 pembrolizumab 3 fludarabine phosphate 3 Doxorubicin 3 Biopsy 3 tanespimycin 2 poly ICLC 2 pegfilgrastim 2 lorukafusp alfa 2 liposomal doxorubicin 2 dinutuximab 2 cabozantinib 2 belinostat 2 Topotecan 2 Thalidomide 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Osteosarcoma × Radiosurgery × Clear all

NCT06492954 2026-03-02

AflacST2301

Emory University

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡